FindTrial
Sign In

Study of effectiveness of Vyoshadi Vati given with and without Surasasidhha taila nasya for 21 days in Allergic rhinitis patients.

A randomized comparative clinical study to evaluate add on effect of Surasasidhha taila nasya with Vyoshadi vati in Allergic Rhinitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024478
Enrollment
60
Registered
2020-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Surasasidhha taila nasya with Vyoshadi vati: Group A will be treated with Surasasidhha taila nasya containing surasa sidhha tila taila and vyoshadi vati containing trikatu, talispatra,

Sponsors

Principal PDEAs college of ayurved and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are having following symptoms 1. Recurrent sneezing 2. Watery rhinorrhoea 3. Nasal obstruction

Exclusion criteria

Exclusion criteria: 1. Known cases of chronic non specific infective rhinitis like hypertrophic rhinitis, atrophic rhinitis, rhinitis sicca, rhinitis caseosa, malignant granuloma. 2. Known cases of chronic specific infective rhinitis like syphilis, leprosy, T.B., lupus vulgaris, rhinosporidiosis, rhinoscleroma, fungal infections and leishmaniasis. 3. Patients with known case of systemic illnesses like hypertension, diabetes mellitus, HIV and HbSAg. 4. Patients with DNS, nasal polyps, tumors, malignancy of any kind. 5. Pregnant women.

Design outcomes

Primary

MeasureTime frame
To compare add on effects of Surasasidhha taila nasya 2 drops in each nostril at morning to Vyoshadi vati 250 mg 2 tablets twice daily after meal for 21 days in Allergic rhinitis patients of age group 18 years to 50 years.Timepoint: 21 days with follow up on 8th, 15th, 22nd day and 1 month after completion of the treatment.—

Secondary

MeasureTime frame
To observe the adverse effects of the drugs if any.Timepoint: 21 days with follow up on 8th, 15th, 22nd day and 1 month after completion of the treatment.—

Countries

India

Contacts

Public ContactDr Chandana Virkar

PDEAS College of Ayurved and Research centre, Akurdi, Pune

virkar.chandana@gmail.com9822199107

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026